This report contains market size and forecasts of Insomnia Pharmacological Treatment in Global, including the following market information:
Global Insomnia Pharmacological Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Insomnia Pharmacological Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Insomnia Pharmacological Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Insomnia Pharmacological Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Insomnia Pharmacological Treatment Market Segment Percentages, By Type, 2020 (%)
Prescription Sleep Aids
Over-the-Counter Sleep Aids
China Insomnia Pharmacological Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Insomnia Pharmacological Treatment Market Segment Percentages, By Application, 2020 (%)
Homecare
Clinic
Hospital
Global Insomnia Pharmacological Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Insomnia Pharmacological Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Insomnia Pharmacological Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Insomnia Pharmacological Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Eisai, Co. Ltd. (Japan)
Merck & Co., Inc (US)
Meda Consumer Healthcare Inc (US)
Pfizer, Inc (US)
Sanofi (France)
Takeda Pharmaceutical Company Ltd. (Japan)
Pernix Therapeutics (US)
Purdue Pharma L.P (US)
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Insomnia Pharmacological Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insomnia Pharmacological Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insomnia Pharmacological Treatment Overall Market Size
2.1 Global Insomnia Pharmacological Treatment Market Size: 2021 VS 2027
2.2 Global Insomnia Pharmacological Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Insomnia Pharmacological Treatment Players in Global Market
3.2 Top Global Insomnia Pharmacological Treatment Companies Ranked by Revenue
3.3 Global Insomnia Pharmacological Treatment Revenue by Companies
3.4 Top 3 and Top 5 Insomnia Pharmacological Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Insomnia Pharmacological Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Insomnia Pharmacological Treatment Players in Global Market
3.6.1 List of Global Tier 1 Insomnia Pharmacological Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Insomnia Pharmacological Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Insomnia Pharmacological Treatment Market Size Markets, 2021 & 2027
4.1.2 Prescription Sleep Aids
4.1.3 Over-the-Counter Sleep Aids
4.2 By Type - Global Insomnia Pharmacological Treatment Revenue & Forecasts
4.2.1 By Type - Global Insomnia Pharmacological Treatment Revenue, 2016-2021
4.2.2 By Type - Global Insomnia Pharmacological Treatment Revenue, 2022-2027
4.2.3 By Type - Global Insomnia Pharmacological Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Insomnia Pharmacological Treatment Market Size, 2021 & 2027
5.1.2 Homecare
5.1.3 Clinic
5.1.4 Hospital
5.2 By Application - Global Insomnia Pharmacological Treatment Revenue & Forecasts
5.2.1 By Application - Global Insomnia Pharmacological Treatment Revenue, 2016-2021
5.2.2 By Application - Global Insomnia Pharmacological Treatment Revenue, 2022-2027
5.2.3 By Application - Global Insomnia Pharmacological Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Insomnia Pharmacological Treatment Market Size, 2021 & 2027
6.2 By Region - Global Insomnia Pharmacological Treatment Revenue & Forecasts
6.2.1 By Region - Global Insomnia Pharmacological Treatment Revenue, 2016-2021
6.2.2 By Region - Global Insomnia Pharmacological Treatment Revenue, 2022-2027
6.2.3 By Region - Global Insomnia Pharmacological Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Insomnia Pharmacological Treatment Revenue, 2016-2027
6.3.2 US Insomnia Pharmacological Treatment Market Size, 2016-2027
6.3.3 Canada Insomnia Pharmacological Treatment Market Size, 2016-2027
6.3.4 Mexico Insomnia Pharmacological Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Insomnia Pharmacological Treatment Revenue, 2016-2027
6.4.2 Germany Insomnia Pharmacological Treatment Market Size, 2016-2027
6.4.3 France Insomnia Pharmacological Treatment Market Size, 2016-2027
6.4.4 U.K. Insomnia Pharmacological Treatment Market Size, 2016-2027
6.4.5 Italy Insomnia Pharmacological Treatment Market Size, 2016-2027
6.4.6 Russia Insomnia Pharmacological Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Insomnia Pharmacological Treatment Market Size, 2016-2027
6.4.8 Benelux Insomnia Pharmacological Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Insomnia Pharmacological Treatment Revenue, 2016-2027
6.5.2 China Insomnia Pharmacological Treatment Market Size, 2016-2027
6.5.3 Japan Insomnia Pharmacological Treatment Market Size, 2016-2027
6.5.4 South Korea Insomnia Pharmacological Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Insomnia Pharmacological Treatment Market Size, 2016-2027
6.5.6 India Insomnia Pharmacological Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Insomnia Pharmacological Treatment Revenue, 2016-2027
6.6.2 Brazil Insomnia Pharmacological Treatment Market Size, 2016-2027
6.6.3 Argentina Insomnia Pharmacological Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Insomnia Pharmacological Treatment Revenue, 2016-2027
6.7.2 Turkey Insomnia Pharmacological Treatment Market Size, 2016-2027
6.7.3 Israel Insomnia Pharmacological Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Insomnia Pharmacological Treatment Market Size, 2016-2027
6.7.5 UAE Insomnia Pharmacological Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Eisai, Co. Ltd. (Japan)
7.1.1 Eisai, Co. Ltd. (Japan) Corporate Summary
7.1.2 Eisai, Co. Ltd. (Japan) Business Overview
7.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Major Product Offerings
7.1.4 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Revenue in Global (2016-2021)
7.1.5 Eisai, Co. Ltd. (Japan) Key News
7.2 Merck & Co., Inc (US)
7.2.1 Merck & Co., Inc (US) Corporate Summary
7.2.2 Merck & Co., Inc (US) Business Overview
7.2.3 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Major Product Offerings
7.2.4 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Revenue in Global (2016-2021)
7.2.5 Merck & Co., Inc (US) Key News
7.3 Meda Consumer Healthcare Inc (US)
7.3.1 Meda Consumer Healthcare Inc (US) Corporate Summary
7.3.2 Meda Consumer Healthcare Inc (US) Business Overview
7.3.3 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Major Product Offerings
7.3.4 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Revenue in Global (2016-2021)
7.3.5 Meda Consumer Healthcare Inc (US) Key News
7.4 Pfizer, Inc (US)
7.4.1 Pfizer, Inc (US) Corporate Summary
7.4.2 Pfizer, Inc (US) Business Overview
7.4.3 Pfizer, Inc (US) Insomnia Pharmacological Treatment Major Product Offerings
7.4.4 Pfizer, Inc (US) Insomnia Pharmacological Treatment Revenue in Global (2016-2021)
7.4.5 Pfizer, Inc (US) Key News
7.5 Sanofi (France)
7.5.1 Sanofi (France) Corporate Summary
7.5.2 Sanofi (France) Business Overview
7.5.3 Sanofi (France) Insomnia Pharmacological Treatment Major Product Offerings
7.5.4 Sanofi (France) Insomnia Pharmacological Treatment Revenue in Global (2016-2021)
7.5.5 Sanofi (France) Key News
7.6 Takeda Pharmaceutical Company Ltd. (Japan)
7.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Corporate Summary
7.6.2 Takeda Pharmaceutical Company Ltd. (Japan) Business Overview
7.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Major Product Offerings
7.6.4 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Revenue in Global (2016-2021)
7.6.5 Takeda Pharmaceutical Company Ltd. (Japan) Key News
7.7 Pernix Therapeutics (US)
7.7.1 Pernix Therapeutics (US) Corporate Summary
7.7.2 Pernix Therapeutics (US) Business Overview
7.7.3 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Major Product Offerings
7.4.4 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Revenue in Global (2016-2021)
7.7.5 Pernix Therapeutics (US) Key News
7.8 Purdue Pharma L.P (US)
7.8.1 Purdue Pharma L.P (US) Corporate Summary
7.8.2 Purdue Pharma L.P (US) Business Overview
7.8.3 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Major Product Offerings
7.8.4 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Revenue in Global (2016-2021)
7.8.5 Purdue Pharma L.P (US) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Insomnia Pharmacological Treatment Market Opportunities & Trends in Global Market
Table 2. Insomnia Pharmacological Treatment Market Drivers in Global Market
Table 3. Insomnia Pharmacological Treatment Market Restraints in Global Market
Table 4. Key Players of Insomnia Pharmacological Treatment in Global Market
Table 5. Top Insomnia Pharmacological Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Insomnia Pharmacological Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Insomnia Pharmacological Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Insomnia Pharmacological Treatment Product Type
Table 9. List of Global Tier 1 Insomnia Pharmacological Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insomnia Pharmacological Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Eisai, Co. Ltd. (Japan)
Merck & Co., Inc (US)
Meda Consumer Healthcare Inc (US)
Pfizer, Inc (US)
Sanofi (France)
Takeda Pharmaceutical Company Ltd. (Japan)
Pernix Therapeutics (US)
Purdue Pharma L.P (US)